These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 4601671)

  • 41. Streptozotocin in the treatment of cancer: phase II study.
    Strolinsky DC; Sadoff L; Braunwald J; Bateman JR
    Cancer; 1972 Jul; 30(1):61-7. PubMed ID: 4261143
    [No Abstract]   [Full Text] [Related]  

  • 42. Complications of antibiotic therapy.
    Ziment I
    Calif Med; 1972 Nov; 117(5):24-48. PubMed ID: 4264289
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Randomized prospective trial of DTIC (NSC-45388) alone versus BCNU (NSC-409962) plus vincristine (NSC-67574) in the treatment of metastatic malignant melanoma.
    Bellett RE; Mastrangelo MJ; Laucius JF; Bodurtha AJ
    Cancer Treat Rep; 1976 May; 60(5):595-600. PubMed ID: 791478
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Toxicity of antibacterial agents: mechanism of action on mammalian cells.
    Sanders WE; Sanders CC
    Annu Rev Pharmacol Toxicol; 1979; 19():53-83. PubMed ID: 222202
    [No Abstract]   [Full Text] [Related]  

  • 45. Clinical trial of the oral form of a new podophyllotoxin derivative, VP-16-213 (NSC-141540), in patients with advanced neoplastic disease.
    Nissen NI; Hansen HH; Pedersen H; Stroyer I; Dombernowsky P; Hessellund M
    Cancer Chemother Rep; 1975; 59(5):1027-9. PubMed ID: 1106845
    [No Abstract]   [Full Text] [Related]  

  • 46. L-asparaginase (NSC-109229) plus azaserine (NSC-742) in acute lymphatic leukemia.
    Leventhal BG; Skeel RT; Yankee RA; Henderson ES
    Cancer Chemother Rep; 1970 Feb; 54(1):47-51. PubMed ID: 4945997
    [No Abstract]   [Full Text] [Related]  

  • 47. Phase I clinical studies with gallium nitrate.
    Bedikian AY; Valdivieso M; Bodey GP; Burgess MA; Benjamin RS; Hall S; Freireich EJ
    Cancer Treat Rep; 1978 Oct; 62(10):1449-53. PubMed ID: 361223
    [No Abstract]   [Full Text] [Related]  

  • 48. Phase I study of twice weekly 5-azacytidine (NSC-102816).
    Vogler WR; Arkun S; Velez-Garcia E
    Cancer Chemother Rep; 1974; 58(6):895-9. PubMed ID: 4141280
    [No Abstract]   [Full Text] [Related]  

  • 49. 5-Fluorouracil (5-Fu; NSC-19893), 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388), vincristine (NSC-67574), and 1,3-bis(2-chloroethyl)-2-nitrosourea (BCNU; NSC-409962) given concomitantly in the treatment of solid tumors in man.
    van Eden EB; Falkson G; van Dyk JJ; van der Merwe AM; Falkson HC
    Cancer Chemother Rep; 1972 Feb; 56(1):107-47. PubMed ID: 5030803
    [No Abstract]   [Full Text] [Related]  

  • 50. Phase II evaluation of chlorozotocin (NSC-178248) in advanced human cancer.
    Talley RW; Samson MK; Brownlee RW; Samhouri AM; Fraile RJ; Baker LH
    Eur J Cancer (1965); 1981 Mar; 17(3):337-43. PubMed ID: 6455296
    [No Abstract]   [Full Text] [Related]  

  • 51. [Study of adverse reactions in pulmonary tuberculosis patients treated with rifampicin].
    Anastasatu C; Dinulică E; Algeorge G; Cărpinişan L; Varga E; Rudescu D
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1975; 24(4):213-9. PubMed ID: 174177
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical studies with 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC 79037).
    Hansen HH; Selawry OS; Muggia FM; Walker MD
    Cancer Res; 1971 Mar; 31(3):223-7. PubMed ID: 4926242
    [No Abstract]   [Full Text] [Related]  

  • 53. Phase I evaluation of DTIC (NSC-45388) and other studies in malignant melanoma in the Central Oncology Group.
    Johnson RO; Metter G; Wilson W; Hill G; Krementz E
    Cancer Treat Rep; 1976 Feb; 60(2):183-7. PubMed ID: 769971
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Phase III study of 5-FU and carmustine versus 5-FU, carmustine, and doxorubicin in advanced gastric cancer.
    Schnitzler G; Queisser W; Heim ME; König H; Katz R; Fritze D; Herrmann R; Arnold H; Henss H; Trux FA
    Cancer Treat Rep; 1986 Apr; 70(4):477-9. PubMed ID: 3516396
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Modulation of O6-alkylguanine-DNA alkyltransferase-mediated carmustine resistance using streptozotocin: a phase I trial.
    Panella TJ; Smith DC; Schold SC; Rogers MP; Winer EP; Fine RL; Crawford J; Herndon JE; Trump DL
    Cancer Res; 1992 May; 52(9):2456-9. PubMed ID: 1533174
    [TBL] [Abstract][Full Text] [Related]  

  • 56. 5-Fluorouracil in childhood solid tumors.
    Haggard ME; Cangir A; Ragab AH; Komp D; Falletta J; Humphrey GB
    Cancer Treat Rep; 1977; 61(1):69-71. PubMed ID: 324621
    [No Abstract]   [Full Text] [Related]  

  • 57. [Complications of antibiotic therapy].
    Cah Med; 1971 Dec; 12(17):1527-38. PubMed ID: 5149498
    [No Abstract]   [Full Text] [Related]  

  • 58. Vinblastine (NSC-49842) plus vincristine (NSC-67574) given in intensive 3-day courses as therapy for lymphomas, sarcomas, and other neoplasms.
    Stolinsky DC; Bogdon DL; Pugh RP; Braunwald J; Hestorff R; Bateman JR
    Cancer Chemother Rep; 1973; 57(4):481-4. PubMed ID: 4586955
    [No Abstract]   [Full Text] [Related]  

  • 59. Clinical experience with mitomycin C (NSC-26980).
    Whittington RM; Close HP
    Cancer Chemother Rep; 1970 Jun; 54(3):195-8. PubMed ID: 4334088
    [No Abstract]   [Full Text] [Related]  

  • 60. [Little noticed active substances of food. On the usefulness and harm of "conutrients". 2].
    Glatzel H
    Med Klin; 1968 Feb; 63(5):161-4. PubMed ID: 5670165
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.